
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
4-Imidazo[2,1-b]thiazole-1,4-DHPs and neuroprotection: preliminary study in hits searching
Alberto Leoni, Maria Frosini, Alessandra Locatelli, et al.
European Journal of Medicinal Chemistry (2019) Vol. 169, pp. 89-102
Open Access | Times Cited: 22
Alberto Leoni, Maria Frosini, Alessandra Locatelli, et al.
European Journal of Medicinal Chemistry (2019) Vol. 169, pp. 89-102
Open Access | Times Cited: 22
Showing 22 citing articles:
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Yong Ling, Zhi‐You Hao, Dong Liang, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 4289-4338
Open Access | Times Cited: 249
Yong Ling, Zhi‐You Hao, Dong Liang, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 4289-4338
Open Access | Times Cited: 249
Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes
Atamjit Singh, Danish Malhotra, Karanvir Singh, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133479-133479
Closed Access | Times Cited: 52
Atamjit Singh, Danish Malhotra, Karanvir Singh, et al.
Journal of Molecular Structure (2022) Vol. 1266, pp. 133479-133479
Closed Access | Times Cited: 52
Design, Synthesis and In‐Silico Studies of Piperidine‐Dihydropyridine Hybrids as Anticancer Agents
Swathi Rejinthala, Srinivas Endoori, Vishnu Thumma, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 6
Swathi Rejinthala, Srinivas Endoori, Vishnu Thumma, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 6
Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside
Maciej Bladowski, Jakub Gawryś, Damian Gajecki, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 40
Maciej Bladowski, Jakub Gawryś, Damian Gajecki, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 40
Visible-Light-Prompted Synthesis and Binding Studies of 5,6-Dihydroimidazo[2,1-b]thiazoles with BSA and DNA Using Biophysical and Computational Methods
Ranjana Aggarwal, Mona Hooda, Prince Kumar, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 6, pp. 3952-3966
Closed Access | Times Cited: 16
Ranjana Aggarwal, Mona Hooda, Prince Kumar, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 6, pp. 3952-3966
Closed Access | Times Cited: 16
Four-Component Fusion Protocol with NiO/ZrO2 as a Robust Recyclable Catalyst for Novel 1,4-Dihydropyridines
Sandeep V. H. S. Bhaskaruni, Suresh Maddila, Werner E. van Zyl, et al.
ACS Omega (2019) Vol. 4, Iss. 25, pp. 21187-21196
Open Access | Times Cited: 28
Sandeep V. H. S. Bhaskaruni, Suresh Maddila, Werner E. van Zyl, et al.
ACS Omega (2019) Vol. 4, Iss. 25, pp. 21187-21196
Open Access | Times Cited: 28
Calcium channel blockers’ contribution to overcoming Current drug discovery challenges in Alzheimer’s disease
Paul J. Bernard, Djamila Bellili, Lhassane Ismaïli
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 1, pp. 21-32
Closed Access | Times Cited: 6
Paul J. Bernard, Djamila Bellili, Lhassane Ismaïli
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 1, pp. 21-32
Closed Access | Times Cited: 6
From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?
Mu Guo, Xiangbin Yu, Yi Zhun Zhu, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5052-5052
Open Access | Times Cited: 5
Mu Guo, Xiangbin Yu, Yi Zhun Zhu, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5052-5052
Open Access | Times Cited: 5
Imidazothiazoles and their Hydrogenated Analogs: Methods of Synthesis and Biomedical Potential
Lesya N. Saliyeva, Iryna Diachenko, Р. И. Васькевич, et al.
Chemistry of Heterocyclic Compounds (2020) Vol. 56, Iss. 11, pp. 1394-1407
Closed Access | Times Cited: 10
Lesya N. Saliyeva, Iryna Diachenko, Р. И. Васькевич, et al.
Chemistry of Heterocyclic Compounds (2020) Vol. 56, Iss. 11, pp. 1394-1407
Closed Access | Times Cited: 10
Synthesis and Evaluation of Antimicrobial and Anti-inflammatory Activity of 6-aryliden-2-methyl-2,3-dihydroimidazo[2,1-b][1,3]thiazoles
Lesya Saliyeva, Serhii Holota, A. N. Grozav, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 1, pp. 292-303
Open Access | Times Cited: 9
Lesya Saliyeva, Serhii Holota, A. N. Grozav, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 1, pp. 292-303
Open Access | Times Cited: 9
3-Aryl-4-nitrobenzothiochromans S,S-dioxide: From Calcium-Channel Modulators Properties to Multidrug-Resistance Reverting Activity
Matteo Micucci, Maurizio Viale, Alberto Chiarini, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1056-1056
Open Access | Times Cited: 8
Matteo Micucci, Maurizio Viale, Alberto Chiarini, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1056-1056
Open Access | Times Cited: 8
Latest Progress in the Development of Multitarget Ligands for Alzheimer's Disease Based on the Hantzsch Reaction
Lhassane Ismaïli, Paul J. Bernard, Bernard Refouvelet
Future Medicinal Chemistry (2022) Vol. 14, Iss. 13, pp. 943-946
Closed Access | Times Cited: 4
Lhassane Ismaïli, Paul J. Bernard, Bernard Refouvelet
Future Medicinal Chemistry (2022) Vol. 14, Iss. 13, pp. 943-946
Closed Access | Times Cited: 4
Multicomponent reactions as a privileged tool for multitarget-directed ligand strategies in Alzheimer’s disease therapy
Sylvain Grosjean, Irène Pachón-Angona, Michella Dawra, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 21, pp. 1583-1606
Closed Access | Times Cited: 4
Sylvain Grosjean, Irène Pachón-Angona, Michella Dawra, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 21, pp. 1583-1606
Closed Access | Times Cited: 4
Synthesis and Evaluation of Bioactivity of 6-[(2-Pyridinyloxy)](Benzo)Imidazo[2,1-b][1,3]Thiazine Derivatives
Lesya Saliyeva, Nataliia Slyvka, Serhii Holota, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 4, pp. 5031-5044
Open Access | Times Cited: 5
Lesya Saliyeva, Nataliia Slyvka, Serhii Holota, et al.
Biointerface Research in Applied Chemistry (2021) Vol. 12, Iss. 4, pp. 5031-5044
Open Access | Times Cited: 5
A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer’s Agents
Mohan L. Gupta, Avinash Kumar, Madhwi Ojha, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 8, pp. 962-976
Closed Access | Times Cited: 3
Mohan L. Gupta, Avinash Kumar, Madhwi Ojha, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 8, pp. 962-976
Closed Access | Times Cited: 3
Designing Imidazo[2,1-B]Thiazole-Based Mesoionic Carbenes Using Quantum Chemical Analysis and Generation of Nl2+ Complexes
Gurudutt Dubey, Aditi Tiwari, Prasad V. Bharatam
(2024)
Closed Access
Gurudutt Dubey, Aditi Tiwari, Prasad V. Bharatam
(2024)
Closed Access
Pharmaceutical perspectives of thiazole analogues: An overview
Archana R. Patil, Basappa C. Yallur, Sampath Chinnam, et al.
Results in Chemistry (2024), pp. 101820-101820
Open Access
Archana R. Patil, Basappa C. Yallur, Sampath Chinnam, et al.
Results in Chemistry (2024), pp. 101820-101820
Open Access
SYNTHESIS AND ANTIOXIDANT ACTIVITY OF 5-CHLORO-2-METHYL-2,3-DIHYDROIMIDAZO[2,1-b][1,3]THIAZOLE-6-CARBALDEHYDE
Olexandr IVANKIV, Mykhailo DIURDIAI, Lesya Saliyeva, et al.
Proceedings of the Shevchenko Scientific Society Series Сhemical sciences (2024) Vol. 2024, Iss. 75, pp. 66-72
Closed Access
Olexandr IVANKIV, Mykhailo DIURDIAI, Lesya Saliyeva, et al.
Proceedings of the Shevchenko Scientific Society Series Сhemical sciences (2024) Vol. 2024, Iss. 75, pp. 66-72
Closed Access
Investigating the potential of novel thiazole derivatives in treating Alzheimer’s and Parkinson’s diseases
Abd Al Rahman Asfour, Asaf Evrim Evren, Begüm Nurpelin Sağlık, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-17
Closed Access
Abd Al Rahman Asfour, Asaf Evrim Evren, Begüm Nurpelin Sağlık, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-17
Closed Access
Convenient Synthesis of 4-pyridinyloxy-Modified imidazo[2,1-b][1,3]thiazines as Potential Anti-inflammatory Agents
Nataliia Slyvka, Lesya Saliyeva, Serhii Holota, et al.
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 2, pp. 183-183
Open Access | Times Cited: 2
Nataliia Slyvka, Lesya Saliyeva, Serhii Holota, et al.
Biointerface Research in Applied Chemistry (2022) Vol. 13, Iss. 2, pp. 183-183
Open Access | Times Cited: 2
Synthesis, the antiexudative and antimicrobial activity of 6-arylidene substituted imidazo[2,1-b]thiazoles
Lesya Saliyeva, Serhii Holota, A. N. Grozav, et al.
Journal of organic and pharmaceutical chemistry (2021) Vol. 19, Iss. 2(74), pp. 29-35
Open Access | Times Cited: 1
Lesya Saliyeva, Serhii Holota, A. N. Grozav, et al.
Journal of organic and pharmaceutical chemistry (2021) Vol. 19, Iss. 2(74), pp. 29-35
Open Access | Times Cited: 1
Synthesis of selected functionalized derivatives of thiazolo[3,2-b][1,2,4]triazole, imidazo[2,1-b]thiazole and imidazo[2,1-b][1,3,4]thiadiazole
N. Pokhodylo
Visnyk of the Lviv University Series Chemistry (2023) Vol. 64, Iss. 1, pp. 255-255
Open Access
N. Pokhodylo
Visnyk of the Lviv University Series Chemistry (2023) Vol. 64, Iss. 1, pp. 255-255
Open Access